retatrutide news today october 2025 (Eli Lilly's triple GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive obesity + osteoarthritis data we've ever seen in the phase 3 TRIUMPH-4 trial: Eli Lilly's Next-Gen Obesity Drug

Body Composition While patients can lose weight with GLP-1s, they can lose some muscle mass as well as fat

Beyond blood sugar control, GLP-1 drugs influence appetite, taste preference, and even reward processing in the brain

J Clin Endocrinol Metab (2017) 102:14513

ShedRx is a healthcare platform offering weight-loss support through personalized guidance and medication management

Every person responds differently Semaglutide usually helps most people feel less hungry and eat less, but not everyone has the same experience, says Registered Dietitian, Karalis, RD

It was indicated for patients not achieving control with oral agents like metformin or sulfonylureas